COVID-19 associated cognitive impairment: A systematic review.

ABSTRACT:

Introduction

COVID-19 has a wide range of clinical manifestations. Neurological manifestations in COVID-19 patients were demonstrated during the pandemic, including cognitive impairment. This study aimed to determine any relationship between COVID-19 and cognitive complaints, such as dementia, mild cognitive impairment (MCI), or subjective cognitive decline (SCD).

Methods

We performed a systematic review of MEDLINE via Ebsco, Cochrane EMBASE, SCOPUS, and LILACS electronic databases of observational studies with COVID-19 patients confirmed by serology or PCR who developed new cognitive impairment or deteriorated from previous cognitive impairment after infection. This review protocol was recorded on PROSPERO with registration number CRD 42021241590.

Results

A total of

SUBMITTER: Tavares-Junior JWL 

PROVIDER: S-EPMC9014565 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature